TJX
51
-7
RSG
54
-3
DNB
66
-4
FMC
17
-6
MPC
23
-5
PGR
49
-6
FCX
40
-5
MNST
44
-2
STT
40
-10
XOM
30
-3
ZBH
53
-7
ED
33
-6
VRTX
44
-14
M
37
-9
ECL
50
-5
XRAY
38
-5
ORCL
45
-5
KO
39
-7
DFS
54
-8
HST
47
-11
TJX
51
-7
RSG
54
-3
DNB
66
-4
FMC
17
-6
MPC
23
-5
PGR
49
-6
FCX
40
-5
MNST
44
-2
STT
40
-10
XOM
30
-3
ZBH
53
-7
ED
33
-6
VRTX
44
-14
M
37
-9
ECL
50
-5
XRAY
38
-5
ORCL
45
-5
KO
39
-7
DFS
54
-8
HST
47
-11
Financhill
Back

Incyte Vs. Syndax Pharmaceuticals Industry Stock Comparison

Sell
40

INCY
Incyte

Last Price:
66.75
Seasonality Move:
15.76%
Sell
30

SNDX
Syndax Pharmaceuticals

Last Price:
13.23
Seasonality Move:
15.76%
Sell
40
Incyte (INCY) is a Sell

Is Incyte a Buy, Sell or Hold?

  • The current Incyte [INCY] share price is $67.58. The Score for INCY is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • INCY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Syndax Pharmaceuticals (SNDX) is a Sell

Is Syndax Pharmaceuticals a Buy, Sell or Hold?

  • The current Syndax Pharmaceuticals [SNDX] share price is $13.24. The Score for SNDX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • SNDX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

INCY Stock Price Chart

What is Incyte's stock price today?

  • The Incyte share price today is $67.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INCY is experiencing selling pressure, which indicates risk of future bearish movement.

SNDX Stock Price Chart

What is Syndax Pharmaceuticals's stock price today?

  • The Syndax Pharmaceuticals share price today is $13.24
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SNDX is experiencing selling pressure, which indicates risk of future bearish movement.

INCY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.15 Sell
Relative Strength Index (14 RSI): 37.18 Sell
Chaikin Money Flow: -1799413 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (70.07 - 76.09) Sell
Bollinger Bands (100): (62.66 - 73.8) Sell

SNDX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.15 Sell
Relative Strength Index (14 RSI): 27.84 Sell
Chaikin Money Flow: -1898565 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.46 - 16.9) Sell
Bollinger Bands (100): (16.52 - 20.66) Sell

INCY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 70.41 Sell
20-day SMA: 72.27 Sell
50-day SMA: 72.12 Sell
200-day SMA: 63.21 Buy
8-day EMA: 70.21 Sell
20-day EMA: 71.95 Sell
50-day EMA: 71.52 Sell
200-day EMA: 65.94 Buy

SNDX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.1 Sell
20-day SMA: 15.55 Sell
50-day SMA: 17.53 Sell
200-day SMA: 20.14 Sell
8-day EMA: 14.18 Sell
20-day EMA: 15.37 Sell
50-day EMA: 16.93 Sell
200-day EMA: 19.14 Sell

Incyte Earnings Growth & INCY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.53 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.30 per share, and an increase next year of $4.72 per share.

Syndax Pharmaceuticals Earnings Growth & SNDX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $1.44 per share.

Incyte Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Syndax Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):